CAS: 3818-37-9; 1-Phenoxypropan-2-Ylhydrazine

该化合物是一种专门性的九氨衍生物,具有苯氧乙基替代物,在1号位置与一个甲基组相配,该化合物对合成有机化学很感兴趣,因为它具有作为制药,农用化学品和精美化学品制作的多种用途中间体的潜力.芬氧乙基组的存在增强了其在核生殖替代和凝聚反应中的回动性和选择性.其结构特性还有助于在某些反应条件下提高溶性性和稳定性.研究人员认为这种衍生物具有促进复杂环绕框架和功能化氢氨化合物合成的能力,使其成为有针对性的合成应用中的有用的试剂.

结构式图片

上下游产品

1-苯氧基-丙醇 1-Phenoxy-2-Propanol 770-35-4
(2-Bromopropoxy)Benzene 90561-10-7

合成工艺路线路线简述

    📜1-苯氧基-丙醇置于三溴化磷,一水合肼体系中,用 乙醇 作为反应溶剂,化学反应 2.0H,反应生成 苯氧丙肼
    参考文献:单胺氧化酶抑制剂.一系列取代的烷基肼的合成与评估.
    标题:单胺氧化酶抑制剂.一系列取代的烷基肼的合成与评估.
    摘要:
    DOI:10.1021/jm00337A015

    海关参考信息

    专利信息


    专利号:US-4005179-A
    优先权日:1974-07-27
    标 题 :Working up synthesis solutions obtained in production of hydrazine
    发明人:EICHENHOFER KURT-WILHELM; SCHLIEBS REINHARD; BRANDL HERMANN; KOHNEN HEINRICH
    权利人:BAYER AG
    摘要:In the production of hydrazine wherein aqueous ammonia is oxidized in the presence of a ketone to form an aqueous solution containing at least one of a hydrazone and a ketazine along with ammonia, the hydrazone and ketazine are concentrated and the hydrazone and ketazine are subsequently hydrolyzed to hydrazine and ketone, the improvement which comprises effecting the concentration of the hydrazone and ketazine by extracting the aqueous solution with a substantially water-immiscible organic solvent whereby the hydrazone and ketazine preferentially enter the water-immiscible solvent, and separating the water-immiscible solvent extract from the aqueous solution. The organic solvent is preferably a higher alcohol, a chlorinated hydrocarbon, benzene or a substitution product thereof. The organic solvent extract, in one or more stages, and optionally with addition of ketone, can be re-extracted with water, hydrolyzed with aqueous acid or subjected to distillation to separate the hydrazine values from the organic solvent.

    专利号:EP-1233944-A2
    优先权日:1999-11-21
    标题 :Coupling condensation synthesis of heterocycles

    专利号:WO-0138302-A2
    优先权日:1999-11-21
    标 题 :Coupling condensation synthesis of heterocycles

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.drudis.2011.05.007
    摘要:Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011 Aug;16(15-16):697–703. doi: 10.1016/j.drudis.2011.05.007.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知